KINDLER JEFFREY B — SEC insider filings

SEC reporting owner CIK 1174454. 37 insider filings on record with FilingPulse; latest filed 2026-08-28.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2021-03-16 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PRECIGEN, INC. (PGEN)Director16—6 legs · 741,513 sh · $3,087,81830
PERRIGO Co plc (PRGO)Director8—1 leg · 17,598 sh · $497,49520
Terns Pharmaceuticals, Inc. (TERN)Director9——17
Praxis Precision Medicines, Inc. (PRAX)Director2——5
PPD, Inc. (PPD)Director2——3

Insider filings — KINDLER JEFFREY B

FiledFormIssuerReported transactionsSource
2026-08-284PRECIGEN, INC. (PGEN)Sale (S): 185,000 @ $7.44EDGAR
2026-06-124Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 1,371 @ $0 · Grant/award (A): 648 (derivative) @ $0EDGAR
2026-05-054Terns Pharmaceuticals, Inc. (TERN)Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 10,657 (derivative) · Disposition to issuer (D): 4,676 (derivative) · Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 28,475 (derivative) · +3 moreEDGAR
2026-03-164PRECIGEN, INC. (PGEN)Option exercise (M): 71,839 · Option exercise (M): 71,839 (derivative) @ $0EDGAR
2026-03-124PRECIGEN, INC. (PGEN)Grant/award (A): 19,658 @ $3.51 · Grant/award (A): 35,612 (derivative) @ $0 · Grant/award (A): 41,073 (derivative) @ $0EDGAR
2026-02-104Praxis Precision Medicines, Inc. (PRAX)Grant/award (A): 688 @ $0 · Grant/award (A): 478 @ $0 · Grant/award (A): 224 (derivative) @ $0EDGAR
2026-02-024Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 1,697 (derivative) @ $0EDGAR
2025-12-164PRECIGEN, INC. (PGEN)Sale (S): 235,467 @ $3.63EDGAR
2025-10-014PRECIGEN, INC. (PGEN)Sale (S): 67,523 @ $3.60 · Sale (S): 106,837 @ $3.38EDGAR
2025-06-124Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-05-164PERRIGO Co plc (PRGO)Option exercise (M): 9,904 @ $26.01 · Tax withholding (F): 4,754 @ $26.01 · Grant/award (A): 7,305 (derivative) · Option exercise (M): 9,904 (derivative)EDGAR
2025-03-174PRECIGEN, INC. (PGEN)Grant/award (A): 39,655 @ $1.74 · Option exercise (M): 87,412 · Grant/award (A): 71,839 (derivative) @ $0 · Option exercise (M): 87,412 (derivative) @ $0 · Grant/award (A): 83,517 (derivative) @ $0EDGAR
2025-02-034Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 10,657 (derivative) @ $0EDGAR
2024-12-104PERRIGO Co plc (PRGO)Sale (S): 17,598 @ $28.27EDGAR
2024-07-024Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 4,676 (derivative) @ $0EDGAR
2024-06-144Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2024-05-164PERRIGO Co plc (PRGO)Option exercise (M): 8,764 @ $30.22 · Tax withholding (F): 4,207 @ $30.22 · Grant/award (A): 9,904 (derivative) · Option exercise (M): 8,764 (derivative)EDGAR
2024-03-184PRECIGEN, INC. (PGEN)Grant/award (A): 48,251 @ $1.43 · Grant/award (A): 87,412 (derivative) @ $0 · Grant/award (A): 101,626 (derivative) @ $0EDGAR
2024-03-124PRECIGEN, INC. (PGEN)Option exercise (M): 106,837 · Option exercise (M): 106,837 (derivative) @ $0EDGAR
2023-12-294PRECIGEN, INC. (PGEN)Sale (S): 96,686 @ $1.41EDGAR
2023-06-144Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2023-05-194PERRIGO Co plc (PRGO)Option exercise (M): 7,778 @ $32.86 · Tax withholding (F): 3,734 @ $32.86 · Option exercise (M): 7,778 (derivative)EDGAR
2023-05-174PERRIGO Co plc (PRGO)Grant/award (A): 8,764 (derivative)EDGAR
2023-03-134PRECIGEN, INC. (PGEN)Grant/award (A): 58,974 @ $1.17 · Grant/award (A): 106,837 (derivative) @ $0 · Grant/award (A): 125,489 (derivative) @ $0EDGAR
2023-02-244PRECIGEN, INC. (PGEN)Option exercise (M): 61,576 · Option exercise (M): 61,576 (derivative) @ $0EDGAR
2022-08-154PRECIGEN, INC. (PGEN)Sale (S): 50,000 @ $2.30EDGAR
2022-06-214Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2022-05-194PERRIGO Co plc (PRGO)Option exercise (M): 6,599 @ $38.57 · Tax withholding (F): 3,168 @ $38.57 · Grant/award (A): 7,778 (derivative) · Option exercise (M): 6,599 (derivative)EDGAR
2022-03-294PRECIGEN, INC. (PGEN)Option exercise (M): 16,212 · Option exercise (M): 16,212 (derivative) @ $0EDGAR
2022-02-244PRECIGEN, INC. (PGEN)Grant/award (A): 33,990 @ $2.03 · Grant/award (A): 61,576 (derivative) @ $0 · Grant/award (A): 83,189 (derivative) @ $0EDGAR
2021-12-084PPD, Inc. (PPD)Disposition to issuer (D): 99,487 @ $47.50 · Disposition to issuer (D): 18,500 @ $47.50EDGAR
2021-09-304Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2021-05-194PERRIGO Co plc (PRGO)Grant/award (A): 6,599 (derivative)EDGAR
2021-05-114PERRIGO Co plc (PRGO)Option exercise (M): 5,804 @ $42.96 · Tax withholding (F): 2,786 @ $42.96 · Option exercise (M): 5,804 (derivative)EDGAR
2021-04-274PPD, Inc. (PPD)Grant/award (A): 2,164 @ $0EDGAR
2021-03-294PRECIGEN, INC. (PGEN)Grant/award (A): 8,949 @ $7.71 · Grant/award (A): 16,212 (derivative) @ $0 · Grant/award (A): 22,107 (derivative) @ $0EDGAR
2021-03-164PRECIGEN, INC. (PGEN)Option exercise (M): 62,189 · Option exercise (M): 62,189 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1174454 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs